Mahnaz Rezaei

Mahnaz Rezaei

Auto-generated profile, based on publicly available information

Mahnaz Rezaei

Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan 9816743175, Iran

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2019 in Apoptosis
Verified
Journal Article
Closed access
PDF file
AMAbbas Mohammadpour-Gharehbagh
Abbas Mohammadpour-Gharehbagh
DJDanial Jahantigh
Danial Jahantigh
MEMoein Eskandari
Moein Eskandari
MSMahdiyeh Harati Sadegh
Mahdiyeh Harati Sadegh
MNMohammad Hadi Nematollahi
Mohammad Hadi Nematollahi
SSSaeedeh Salimi
Saeedeh Salimi

2 February 2016 in Biomedical Reports
Verified
Journal Article
Open access
PDF file
SSSaeedeh Salimi
Saeedeh Salimi
MNMehrangiz Noora
Mehrangiz Noora
SNSima Nabizadeh
Sima Nabizadeh
MRMahnaz Rezaei
Mahnaz Rezaei
HSHossain Shahraki
Hossain Shahraki
MSMahnaz Sandoughi
Mahnaz Sandoughi
Osteopontin (OPN) is a chemokine-like glycoprotein that has a prominent role in regulating inflammation and immunity. OPN polymorphisms and elevated OPN levels are associated with systemic lupus erythematosus (SLE) in several populations. The aim of present study was to evaluate the association between the OPN rs1126616 polymorphism and OPN level with SLE susceptibility. A total of 163 SLE patients and 180 age-, gender- and ethnically matched controls were genotyped for the rs1126616 polymorphism by the polymerase chain reaction-restriction fragment length polymorphism method. Serum OPN levels were assayed by the enzyme-linked immunosorbent assay. There was no association between the OPN rs1126616 C/T polymorphism and SLE. The frequency of the OPN rs1126616 CT genotype was significantly higher in SLE patients with nephritis compared to SLE patients without nephritis and controls. Additionally, the frequency of TT genotypes was higher in SLE patients with nephritis compared to controls. The serum OPN levels were significantly higher in SLE patients compared to controls (50.6±22 vs. 35.6±15.8 ng/ml, P<0.001). Increased serum OPN levels were observed in SLE patients with lupus nephritis and joint symptoms. There was no correlation between OPN levels and the OPN rs1126616 polymorphism. The present data suggest that the CT and TT genotypes of the OPN rs1126616 polymorphism could be a risk factor for lupus nephritis. The OPN level is associated with SLE and certain SLE manifestations. However, there was no association between the OPN rs1126616 C/T polymorphism and SLE susceptibility.

1 February 2018 in Cytokine
Verified
Journal Article
Closed access
DJDanial Jahantigh
Danial Jahantigh
MMMahdieh Mousavi
Mahdieh Mousavi
FFForough Forghani
Forough Forghani
MJMohammad Reza Javan
Mohammad Reza Javan
SMSamaneh Movahedinia
Samaneh Movahedinia
MRMahnaz Rezaei
Mahnaz Rezaei

1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
ZHZahra Heidari
Zahra Heidari
SSSaeedeh Salimi
Saeedeh Salimi
MRMohsen Rokni
Mohsen Rokni
MRMahnaz Rezaei
Mahnaz Rezaei
NKNeshat Khalafi
Neshat Khalafi
MSMohsen Saravani
Mohsen Saravani
Background. Grave’s disease (GD) and Hashimoto’s thyroiditis (HT) are autoimmune diseases of the thyroid gland in which genetic predisposition plays a major role in their development. Currently, the role of NLRP3 inflammasome and COX‐2 has been documented in many autoimmune diseases. The purpose of the study is to delineate the impact of IL‐1β (rs1143634), NLRP3 (rs3806265), and COX‐2 (rs2745557) gene polymorphisms in the development of GD and HT. Methods. A total of 256 newly diagnosed patients with autoimmune thyroid disease (135 patients with HT and 121 GD patients) as case groups and 145 controls were included in the study. Results. Recessive and overdominant models showed a significant association between IL‐1β rs1143634 SNP and HT development risk. The frequency of TT genotype and T allele of IL‐1β rs1143634 SNP in the control group was significantly higher than the GD group. There was no significant association between NLRP3 rs3806265 polymorphism and HT and GD development. The frequency of GA genotype of COX‐2 (rs2745557) in the control group was significantly higher than that in the HT group. There was no significant association between COX‐2 rs2745557 genotypic and allelic distribution and GD development risk. The results revealed a significant relationship between some clinical features of HT and GD groups and SNPs studied. Conclusion. The results manifest the significant impact of IL‐1β rs1143634 and COX‐2 (rs2745557) SNPs and HT development and IL‐1β rs1143634 SNP on GD occurrence risk. Furthermore, a significant relationship was observed between some clinical features of HT and GD groups and studied SNPs.

20 April 2019 in Clinical and Experimental Hypertension
Verified
Journal Article
Closed access
FFFarzaneh Farajian-Mashhadi
Farzaneh Farajian-Mashhadi
FEFatemeh Eskandari
Fatemeh Eskandari
MRMahnaz Rezaei
Mahnaz Rezaei
FEFarzaneh Eskandari
Farzaneh Eskandari
DNDarya Najafi
Darya Najafi
SSSaeedeh Salimi
Saeedeh Salimi
Purpose: Vitamin D deficiency may be a main causative agent in the pathogenesis of preeclampsia (PE). The actions of the active form of vitamin D are mediated via the vitamin D receptor (VDR), which is expressed in numerous organs including placenta. Therefore, we evaluated the potential relationship between maternal and placental VDR polymorphisms and the predisposition to PE in an Iranian population. Methods: This case–control study surveyed 152 PE and 160 normotensive pregnant women. The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method was performed to examine the maternal and placental VDR Fok1 rs2228570, Bsm1 rs1544410, Taq1 rs731236, and Apa1 rs7975232 polymorphisms. Results: The maternal but not placental VDR FokI Ff genotype, was significantly lower in PE women (P = .02 and P = .06, respectively). The maternal and placental VDR FokI polymorphism was associated with lower PE risk in the dominant model (Ff+ff vs. FF) and these genotypes could decrease PE risk (OR, 0.5 [95% CI, 0.3–0.8], P = .007 and OR, 0.5 [95% CI, 0.3–0.9], P = .02, respectively). The haplotype analysis revealed that the maternal and placental TABf haplotype may lead to decreased risk of PE. In addition, the placental TABF haplotype was associated with higher risk of PE. No relationship was observed between PE susceptibility and the maternal and placental VDR Bsm1, Taq1 and Apa1 polymorphisms. There was also no relationship between the maternal and placental VDR polymorphisms and PE severity. Conclusions: the maternal and placental VDR FokI variant was associated with decreased risk of PE in the dominant model.

6 May 2019 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
AMAbbas Mohammadpour-Gharehbagh
Abbas Mohammadpour-Gharehbagh
DJDanial Jahantigh
Danial Jahantigh
MEMoein Eskandari
Moein Eskandari
FEFatemeh Eskandari
Fatemeh Eskandari
MRMahnaz Rezaei
Mahnaz Rezaei
SSSaeedeh Salimi
Saeedeh Salimi